SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) against certain of its officers and directors for alleged breaches of fiduciary duty.
Source: globenewswire
Country: United States